Measures CA 19-9 in blood, a tumor-associated marker. Levels can be raised in pancreatic and other gastrointestinal cancers, and also in some benign bile-duct issues.
Used mainly to monitor known pancreatic cancer (treatment response or recurrence). It may also support workup of suspected pancreatic/bile-duct disease with other tests.